Diabetes National Research Group
Nonprofit profile at a glance
- EIN
- 330950812
- IRS 990 coverage
- 2010–2020
- Forms available
- Form 990 2020
- Location
- Port Saint Lucie, FL, USA
- Phone
- 7723454800
- Rating
- 69
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Single Organization Support
Reported finances
- Revenue
- $6,306
- Expenses
- $33,820
- Assets
- $0
- Liabilities
- $0
Source: IRS Form 990. Selected filing: tax year 2020. Amounts in USD.
Leadership & pay
5 people listed
Executive titles in this filing
- RICHARD A HOUGHTEN (PRESIDENT/TRUSTEE)
Highest reported compensation
- PAMELA G HOUGHTEN (SECRETARY): $12,691 total reported compensation
Source: IRS Form 990. Selected filing: tax year 2020. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Diabetes national research group (dnrg)supports fundamental research to find treatments and possible cures, including vaccines, for type 1 and type 2 diabetes. A deadly disease, diabetes occurs when the pancreas does not produce or properly use the hormone called insulin. This hormone is needed for every day life. The need for continued research towards treatments and cures is strong, and dnrg is committed to support research, collaborations, and education of the public, in order to make a difference.
What it reported doing in 2020
In type 1 diabetes, cells in the pancreas that produce insulin are "attacked" by the body's own t-cells. T-cells are the body's immune cells whose job it is to destroy invading organisms. But in type 1 diabetes, these t-cells also attack the body that they are supposed to protect. Funded by the national institutes of health and the diabetes national research group, scientists in san diego are beginning to understand how the pancreatic self-antigens (substances capable of inducing an immune response)are processed and presented. Many granting agencies do not provide sufficient funds to cover unexpected expenses, to purchase vital laboratory equipment, or to support scientists' travel to meet with others in the field. By providing supplemental grant funds, the diabetes national research group is in effect working in partnership with other granting organizations to ensure that this important work continues. During the past year, diabetes national research group provided support for these types of supplemental or "cost sharing" programs. Dnrg awarded grants for research projects related to type 1 and type 2 diabetes. Funds were used for new laboratory equipment, laboratory supplies, scientists' salaries, and travel to scientific meetings. Travel to meetings is crucial in order to establish and maintain collaborations with other scientists throughout the world, and to share research results. Dnrg also supported program activities throughout the year including distribution of educational materials and oral presentations to the general public. Activities conducted by diabetes national research group have resulted in an enormous benefit to scientists throughout the world. Over the past few years, publications, oral presentations, collaborations and the sharing of research results with scientists and students occurred in many countries. As a result of this support within the united states, scientists and students from at least half of the states have benefited by attending lectures, reading journal articles, beginning new research collaborations, and maintaining established collaborative efforts.
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- Grant intermediary. The nonprofit sent 83% of its reported program spending out as grants.
The verdict
SUPPORTED - A large share of available resources goes toward mission work and most filed governance safeguards are in place. Few specific pay-setting methods are documented in the filing; unanswered boxes are not proof of absence and the filing reports few safeguards for money sent abroad.
Rating breakdown
- Financial Efficiency: 88
- Transparency & Controls: 57
- Accountability: 72
- Sustainability: 4
- Growth: 40
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 100%; rating input score 100
- Program expense ratio: 96.7%; rating input score 97
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 62nd percentile among comparable filings
- Pay-setting controls: 0 of 6 controls in place; rating input score 0
- Compensation committee: Missing
- Independent consultant: Missing
- Other Form 990s reviewed: Missing
- Written employment contract: Missing
- Compensation survey or study: Missing
- Board or committee approval: Missing
- Foreign activity oversight: 0 of 8 controls in place; rating input score 0
- Claims monitoring procedures: Limited
- Requires narrative reports: Limited
- Conducts field audits: Limited
- May suspend future funding: Limited
- Requires financial reports: Limited
- Conducts site visits: Limited
- Requires grant agreements: Limited
- May require repayment: Limited
- Grant itemization coverage: 100%; rating input score 100; 80th percentile among comparable filings
- Major donor itemization: Limited
- Related-party transparency: Scored; rating input score 0
Accountability
- Independent voting board: 60%; rating input score 60; 20th percentile among comparable filings
- Governance controls: 7 of 8 controls in place; rating input score 88
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Pass
- CEO compensation review process: NotApplicable
- Other executive compensation review process: Fail
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Pass
- Audit committee oversight: Pass
- Independent financial-statement audit: Pass
Sustainability
- Operating margin: -436.3%; rating input score 8; 8th percentile among comparable filings
- Total-asset coverage ratio: 0; rating input score 2; 2nd percentile among comparable filings
- Liabilities to assets ratio: Limited
- Officer compensation ratio: Limited
Growth
- Program expense growth: 7.8% per year; rating input score 100; 81st percentile among comparable filings
- Revenue growth: -28.1% per year; rating input score 0; 16th percentile among comparable filings
- Asset growth: -14.1% per year; rating input score 0; 11th percentile among comparable filings
Details
- Where the money goes: 100% of revenue deployed · 96.7% of spending went to programs
- Governance: 3 of 5 board members independent · 7 of 8 filing controls reported
- Programs: 1 filed program accomplishment · $33K in reported program spending
- Leadership: top reported pay $13K · 5 people listed · 0 of 6 pay-setting controls reported
- Consistency: 19 of 19 current checks pass
- Schedules: 8 filed schedules · includes foreign activity, grants, executive pay, and related organizations
- Filing history: 10 filing years from 2010 to 2020
- Contacts: How to reach this organization
- Money network: 1 filed money-flow record
- Related organizations: 5 filed related-organization links
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
Grant-readiness screening is separate from the live rating, not a measure of program quality. Review the source records before making a grant decision.
- High — Transparency & Controls: Pay-setting controls scored 0/100.
- High — Transparency & Controls: Foreign activity oversight scored 0/100.
- High — Sustainability: Operating margin scored 8/100.
- High — Growth: Revenue growth scored 0/100.
- High — Sustainability: Total-asset coverage ratio scored 2/100.
- High — Transparency & Controls: Related-party transparency scored 0/100.
- Review — Accountability: Governance controls: Other executive compensation review process not reported.
- High — Growth: Asset growth scored 0/100.
- High — Grant Readiness: Automatic revocation: this organization had its federal tax-exempt status automatically revoked.